(Q73038843)

English

Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)

scientific article published on 01 October 2000

Statements

Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit